N@N

The Medicines Company: The Medicines Company to Participate in the UBS Global Life Sciences Conference

^{Published on 2009-09-16 13:43:53 - Market Wire}
 

PARSIPPANY, NJ--(Marketwire - September 16, 2009) - The Medicines Company (NASDAQ: [ MDCO ]) is scheduled to participate in the UBS Global Life Sciences Conference on Wednesday, September 23rd, 2009. John Kelley, President and Chief Operating Officer, will present at 9:00am Eastern Time. A company overview will be provided in the presentation.

The session will be webcast with a link available at The Medicines Company's website: [ http://www.themedicinescompany.com ].

About The Medicines Company

The Medicines Company (NASDAQ: [ MDCO ]) is focused on advancing the treatment of critical care patients through the delivery of innovative, cost-effective medicines to the worldwide hospital marketplace. The Company markets Angiomax® (bivalirudin) in the United States and other countries for use in patients undergoing coronary angioplasty, and Cleviprex® (clevidipine butyrate) injectable emulsion in the United States for the reduction of blood pressure when oral therapy is not feasible or not desirable. The Medicines Company's website is [ www.themedicinescompany.com ].